Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United States

J Pers Med. 2022 Jun 22;12(7):1025. doi: 10.3390/jpm12071025.

Abstract

Despite evidence that precision medicine (PM) results in improved patient care, the broad adoption and implementation has been challenging across the United States (US). To better understand the perceived barriers associated with PM adoption, a quantitative survey was conducted across five stakeholders including medical oncologists, surgeons, lab directors, payers, and patients. The results of the survey reveal that stakeholders are often not aligned on the perceived challenges with PM awareness, education and reimbursement, with there being stark contrast in viewpoints particularly between clinicians, payers, and patients. The output of this study aims to help raise the awareness that misalignment on the challenges to PM adoption is contributing to broader lack of implementation that ultimately impacts patients. With better understanding of stakeholder viewpoints, we can help alleviate the challenges by focusing on multi-disciplinary education and awareness to ultimately improve patient outcomes.

Keywords: healthcare professional (HCP) education; implementation challenges; patient education; payer education; precision medicine; precision oncology; utilization barriers.